Humans harboring SLC4A11 mutations (or mice with a disrupted slc4a11 gene) exhibit contrasting corneal endothelial phenotypes which may help advance our understanding of SLC4A11 dysfunction in CHED. This evidence concerns the gene SLC4A11 and congenital hereditary endothelial dystrophy of cornea.